Celularity Inc. secures financing with Philip Barach for regenerative medicine, with senior secured term loan & secured convertible note.
Today, in Florham Park, New Jersey, Celularity Inc. (Nasdaq: CELU) revealed that it has secured two significant funding agreements. The agreements include a senior secured term loan and a secured convertible note financing with Philip A. Barach, who is the co-founder and ex-president of DoubleLine Capital LP. Celularity focuses on regenerative and cellular medicine for age-related and degenerative diseases. The agreements are subject to the finalization of formal transaction agreements, which is anticipated to occur soon.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments